World leading healthcare evidence, pricing and access congress

Ad Antonisse is a seasoned professional with over 15 years of experience in the pharmaceutical industry, currently serving as the Director of Market Access & Corporate Affairs at AstraZeneca. With a strong background in healthcare pricing, access, and evidence, Ad has a proven track record of...

Professor Dalia Dawoud, PhD, is the Director and CEO of PEHTA Consulting LTD. She has over 15-years’ experience as health economist, researcher and academic. Her work is largely focused on the application of health economics ad outcomes research (HEOR) in HTA and clinical guideline development. She ...

Toon Digneffe is Head of Public Affairs & Public Policy Europe & Canada at Takeda. He has over 25 years’ experience in government affairs, communications, market access and patient advocacy at local, regional and global level.   Mr Digneffe has extensive experience in pharmaceutical...

Gina Ewy is a seasoned professional in the healthcare industry with more than 30 years experience in market access, pricing, value and policy. She is currently the Vice President and Head of Global Market Access at Hansa Biopharma. Her expertise lies in developing and implementing market access...

Lorenzo works as an independent advisor, collaborating with national governments, international organizations, NGOs, and companies to promote innovative regulatory pathways that enhance access to medicines and healthcare while advocating for anti-discrimination initiatives. Previously, he led the...

Alexander Natz is the Secretary General of the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) in Brussels and advises innovative pharmaceutical and biotech companies, including start-ups, in regulatory and pricing & reimbursement matters from the EU law and German law...

Senior international Access & Policy leader, Anh has nearly two decades of experience in Value-Based Healthcare, for better patient access to innovations. She has led strategies that not only unlocked access & premium reimbursement, but also enabled policy change and sustainable adoption...

Siguroli Teitsson is a Director in Global HEOR Economic & Predictive Modeling at Bristol Myers Squibb. In his role, Siguroli leads the advancement of innovative modeling and analytics in oncology, and drives the integration of cutting-edge AI automations in HEOR and market access, streamlining...

Versatile senior leader with diverse public and private sector experience. Licensed health care professional (clinical pharmacist, licensed in Ontario, Canada). 30 years of pharmaceutical industry experience across GSK (Canada), Roche Canada (Vice President for 16 years leading Corporate...

Oliver van Zon has over 20 years of experience in the biopharmaceutical industry spanning market access, pricing, commercial strategy, and finance. Prior to joining Crinetics Pharmaceuticals as Vice President Market Access Europe where he is preparing their European endocrine launches, he held...